ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.585
-0.235 (-4.88%)
At close: Apr 28, 2026, 4:00 PM EDT
4.670
+0.085 (1.85%)
After-hours: Apr 28, 2026, 6:05 PM EDT
ENDRA Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 5 | 3 | 18 | 13 | 29 | |
| Market Cap Growth | 156.17% | 57.21% | -81.25% | 39.49% | -55.93% | 15.68% | |
| Enterprise Value | 6 | 5 | -1 | 15 | 6 | 18 | |
| Last Close Price | 4.82 | 4.53 | 6.26 | 3710.00 | 7122.51 | 24213.02 | |
| PB Ratio | 2.51 | 2.34 | 1.31 | 3.17 | 1.78 | 2.70 | |
| P/TBV Ratio | 2.56 | 2.34 | 1.31 | 3.17 | 1.78 | 2.70 | |
| Debt / Equity Ratio | 0.22 | 0.22 | 0.23 | 0.10 | 0.10 | 0.07 | |
| Net Debt / Equity Ratio | -0.12 | -0.12 | -1.03 | -0.40 | -0.58 | -0.80 | |
| Net Debt / EBITDA Ratio | 0.05 | 0.05 | 0.25 | 0.22 | 0.32 | 0.76 | |
| Net Debt / FCF Ratio | 0.05 | 0.05 | 0.36 | 0.24 | 0.32 | 0.78 | |
| Quick Ratio | 1.01 | 1.01 | 5.34 | 3.14 | 2.87 | 6.13 | |
| Current Ratio | 1.29 | 1.29 | 5.67 | 3.36 | 3.16 | 7.83 | |
| Return on Equity (ROE) | -291.56% | -291.56% | -280.02% | -156.42% | -146.53% | -125.11% | |
| Return on Assets (ROA) | -86.73% | -86.73% | -120.66% | -82.05% | -74.26% | -66.42% | |
| Return on Capital Employed (ROCE) | -185.70% | -185.70% | -281.20% | -179.80% | -173.80% | -101.50% | |
| Earnings Yield | -121.28% | -133.00% | -342.39% | -56.13% | -102.57% | -38.53% | |
| FCF Yield | -89.74% | -98.41% | -220.66% | -53.47% | -100.96% | -38.31% | |
| Buyback Yield / Dilution | -289.41% | -289.41% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.